Lung Cancer
A Phase 2 Trial of Combination Therapies with Adagrasib in Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation (849-017)
- Details
ClinicalTrials.gov ID:
NCT05609578
Diagnosis Type:
NA
USOR Number:
- Address
,
P: